Relevant bibliographies by topics / Interferoni

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Interferoni'

Author: Grafiati
Published: 9 March 2023
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Interferoni.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Interferoni"

1

Cavallo, Giorgio, Marisa Gariglio, Saverio Panico, and Santo Landolfo. "Regolazione delľ espressione genicain vivo da parte degli interferoni." Rendiconti Lincei 1, no. 1 (1990): 105–9. http://dx.doi.org/10.1007/bf03001755.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Betterle, Corrado, and Fabio Presotto. "Terapia con interferoni e autoimmunità organo-specifica: quali rischi e come gestire il paziente." L'Endocrinologo 11, no. 5 (2010): 198–206. http://dx.doi.org/10.1007/bf03344741.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Larsen, Thomas Stauffer, Michael Boe Møller, Karin de Stricker, et al. "Minimal Residual Disease and Normalization of the Bone Marrow after Long-Term Treatment with Alpha-Interferon2b in Polycythemia Vera. A Report on Seven Patients in Sustained Complete Hematological Remission with Major Molecular Responses." Blood 112, no. 11 (2008): 1744. http://dx.doi.org/10.1182/blood.v112.11.1744.1744.

Full text
Abstract:
Abstract Background : Polycythemia vera (PV) is a clonal myeloproliferative disorder characterized by the presence of the JAK2V617 mutation in virtually all patients. Recently several studies have shown that the JAK2V617F mutational load decreases during treatment with alpha-interferon2 (1–6). Aim: To report on molecular and histomorphological bone marrow responses in seven PV patients with complete molecular remissions during and after long-term treatment with alpha-interferon 2b. Patients: Seven patients treated with alpha-interferon2b for a median of 84 months (range 31–120) are reported. I
APA, Harvard, Vancouver, ISO, and other styles
4

Zimring, James C., Stephen Goodbourn, and Margaret K. Offermann. "Human Herpesvirus 8 Encodes an Interferon Regulatory Factor (IRF) Homolog That Represses IRF-1-Mediated Transcription." Journal of Virology 72, no. 1 (1998): 701–7. http://dx.doi.org/10.1128/jvi.72.1.701-707.1998.

Full text
Abstract:
ABSTRACT Human herpesvirus 8 (HHV-8) is the probable viral etiologic agent for Kaposi’s sarcoma. The HHV-8 genome encodes viral interferon regulatory factor (vIRF), a gene product that has homology to the IRF family of transcription factors. We demonstrate that vIRF inhibits responses to type I and type II interferons and blocks IRF-1-mediated transcription. vIRF does not compete with IRF-1 for binding to DNA or complex directly with IRF-1. The ability of vIRF to block IRF-1-mediated transcription is independent of the DNA binding domains of both vIRF and IRF-1. These data suggest that vIRF ma
APA, Harvard, Vancouver, ISO, and other styles
5

Harris, Bethany D., Srilalitha Kuruganti, Ashlesha Deshpande, Paul A. Goepfert, W. Winn Chatham, and Mark R. Walter. "Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine." Lupus 29, no. 9 (2020): 1095–105. http://dx.doi.org/10.1177/0961203320935976.

Full text
Abstract:
Background/objective Type-I interferons contribute to pathogenesis in systemic lupus erythematosus, including nephritis. Interferons consist of a family of 16 proteins yet are often characterized in patients without knowledge of the specific interferon subtypes involved. Different interferons may function in the kidneys, and other organs, relative to what is often measured in patient blood. Moreover, antibodies to interferons may potentially modulate systemic or organ-specific interferon activity. The aim of this study was to characterize global interferon activity levels and identify autoanti
APA, Harvard, Vancouver, ISO, and other styles
6

FNU, Hakim, Muhammed Altinoez Berk, and Ahmad Halim Husban. "Inhaled Interferon for Asthma Treatment (NR): A narrative review." World Journal of Biology Pharmacy and Health Sciences 19, no. 1 (2024): 290–97. https://doi.org/10.5281/zenodo.13789646.

Full text
Abstract:
Although various therapeutic strategies, such as inhalant beta-2 agonists, corticosteroids, anti-leukotrienes, and even novel inclusion of active biological agents in the management of asthma have been established, as asthma is a global issue and chronic in nature, the search for potential new tools to the arsenal continues to this day. Remarkable progress has recently been achieved in identifying the pathophysiology and potential value of interferons (IFNs) in managing allergic asthma. This narrative review attempts to precisely demonstrate the possible use of inhalant IFNs in differing asthm
APA, Harvard, Vancouver, ISO, and other styles
7

Foley, John F. "Interfering with interferons." Science Signaling 9, no. 415 (2016): ec30-ec30. http://dx.doi.org/10.1126/scisignal.aaf4271.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wilks, J., and T. Golovkina. "Interfering with interferons." Science 347, no. 6219 (2015): 233–34. http://dx.doi.org/10.1126/science.aaa5056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mueller, K. L. "Interfering with Interferons." Science Signaling 6, no. 268 (2013): ec75-ec75. http://dx.doi.org/10.1126/scisignal.2004169.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Simpson, S. "Interfering with Interferon." Science's STKE 2007, no. 376 (2007): tw81. http://dx.doi.org/10.1126/stke.3762007tw81.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Interferoni"

1

DETTORI, BEATRICE. "Effetti immunoregolatori degli interferoni di prima classe sull’attivita’ delle cellule CD4+CD25- t helper e delle cellule CD4+CD25+ Treg." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2010. http://hdl.handle.net/2108/1277.

Full text
Abstract:
L’IFN-α è un mediatore di notevole importanza della risposta immunitaria. Tale citochina è in grado di indurre la risposta innata, fornendo lo stimolo per l’attivazione e la formazione della risposta immunitaria acquisita. Lo scopo principale di questo lavoro è determinare se e come IFNα è coinvolto nell’attivazione delle cellule CD4+CD25- T helper (Th) e valutare l’effetto dell’IFN-α sull’attività soppressoria delle cellule CD4+CD25+ T regolatorie (Treg) murine. I nostri risultati mostrano come IFNα promuova la produzione di IL-2 da parte delle cellule CD4+CD25- Th, quando stimolate in pr
APA, Harvard, Vancouver, ISO, and other styles
2

SPOSITO, BENEDETTA. "Type III Interferons: Running Interference with Mucosal Repair." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2023. https://hdl.handle.net/10281/402377.

Full text
Abstract:
Gli interferoni (IFN) sono mediatori e regolatori fondamentali della risposta immunitaria dell'ospite a virus e ad altri agenti microbici. Gli IFN di tipo I e di tipo III (o IFN-λ) sono tra le prime citochine ad essere indotte in seguito a infezioni virali. Il legame tra gli IFN e i rispettivi recettori attiva vie di trasduzione del segnale simili tra loro che inducono l'espressione di geni stimolati dagli IFN (ISG) con funzioni antivirali. La caratteristica principale che rende ciascuna di queste famiglie di IFN unica e non ridondante è l'esistenza di recettori distinti che fanno sì che gli I
APA, Harvard, Vancouver, ISO, and other styles
3

Short, John A. L. "Defective interfering particles of parainfluenza virus subtype 5 and interferon induction." Thesis, University of St Andrews, 2015. http://hdl.handle.net/10023/7036.

Full text
Abstract:
The innate immune response is the first line of defence against virus infection. Cells contain a diverse array of pathogen recognition receptors (PRRs) that are able to recognise multiple pathogen associated molecular patterns (PAMPS) that present themselves during virus infection. The RIG-I (Retinoic acid inducible–gene-I) and MDA5 (melanoma differentiation- associated gene 5) PRRs detect specific viral RNA ligands and subsequently induce the expression of the cytokine Interferon-β(IFN-β). IFN-βis secreted, acting on the infected cell and neighbouring uninfected cells to generate an antiviral
APA, Harvard, Vancouver, ISO, and other styles
4

Jones, Meleri. "Interfering with interferon : developing a reporter system to study the interaction between hepatitus C viral proteins and the interferon signalling pathway." Thesis, Queen Mary, University of London, 2008. http://qmro.qmul.ac.uk/xmlui/handle/123456789/1530.

Full text
Abstract:
The aim of the project was to investigate the mechanism by which HCV evades therapeutic IFN treatment. This involved the development of novel testing systems and their application to patient samples. Initial experiments focused on flavivirus replicons and novel observations on effects of one of these replicons (dengue virus) on interferon signalling were made. The dengue replicon system was demonstrated to inhibit IFNa signalling by reducing the expression of STAT2, an essential component of the type I IFN signalling pathway. This phenomenom was then further examined in dengue virus infected h
APA, Harvard, Vancouver, ISO, and other styles
5

O’Gorman, Maurice R. G. "Reduced in vitro IgG secretion following in vivo injection of interferon (wellferon R) in multiple sclerosis patients." Thesis, University of British Columbia, 1985. http://hdl.handle.net/2429/24876.

Full text
Abstract:
An in vitro IgG secretion assay was developed to investigate the regulation of the humoral immune response in humans. Pokeweed mitogen (PWM), a plant lectin derived from Phytolacca americana stimulates human peripheral blood mononuclear cells (PBMNC) to divide and resting B-lymphocytes to differentiate into immunoglobulin secreting cells (ISC). This differentiation requires that both monocytes and T-lymphocytes be present in the culture system. The amount of IgG secreted by these differentiated B-lymphocytes in response to PWM appears to be the net result of a balance between the functional ac
APA, Harvard, Vancouver, ISO, and other styles
6

Su, Leon L. "Mechanisms of STAT activation via the interferon-[alpha]/[beta] and B cell antigen receptor and immunomodulatory role of interferons on lymphocyte development /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2000. http://wwwlib.umi.com/cr/ucsd/fullcit?p9988315.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Castilló, Justribó Joaquín. "Indicadores precoces de respuesta al tratamiento con interferón en pacientes con esclerosis múltiple." Doctoral thesis, Universitat Autònoma de Barcelona, 2016. http://hdl.handle.net/10803/400286.

Full text
Abstract:
Introducción: el tratamiento con interferón β sigue siendo la terapia inmunomoduladora más extendida en el tratamiento de la esclerosis múltiple remitente-recurrente si bien su eficacia es parcial. En ausencia de un biomarcador específico de respuesta, identificar precozmente a los pacientes que presentan un fallo terapéutico o una respuesta parcial es fundamental para plantear alternativas terapéuticas. Objetivo: estudiar la utilidad de la Multiple Sclerosis Functional Composite para evaluar el acumulo precoz de discapacidad, así como el valor de otras variables clínicas y de RM recogidas e
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Rijian. "Interferons and dermal fibrotic disorders, nitric oxide production and transforming growth factor-ß1 gene expression by normal and hypertrophic dermal fibroblasts and tissues after interferon treatment." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0008/NQ29122.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dominguez, Palao Francisco. "Interferon induction by paramyxoviruses : investigations into specific RNA:protein interactions." Thesis, University of St Andrews, 2017. http://hdl.handle.net/10023/10750.

Full text
Abstract:
RNA:protein interactions are central in many cellular processes, including activation of innate immune responses against microbial infection. Their study is essential to better understand the diverse biological events that occur within cells. However, isolation of RNA:protein complexes is often laborious and requires specialized techniques. This thesis is concerned with attempts to develop an improved purification protocol to isolate specific RNA:protein complexes. Taking advantage of the specific interaction of the Pseudomonas aeruginosa PP7 protein with its cognate RNA binding site, termed t
APA, Harvard, Vancouver, ISO, and other styles
10

Busche, Andreas. "Identifizierung und Charakterisierung von Modulatoren der Interferon-[gamma]-Antwort [Interferon-Gamma-Antwort]." [S.l.] : [s.n.], 2003. http://deposit.ddb.de/cgi-bin/dokserv?idn=96971954X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Interferoni"

1

Joyce, Taylor-Papadimitriou, ed. Interferons: Their impact in biology and medicine. Oxford University Press, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1940-, Stewart William E., and Schellekens Huub, eds. The biology of the interferon system 1985: Proceedings of the 1985 TNO-ISIR Meeting on the Interferon System, held in Clearwater Beach, Florida, USA on 13-18 October, 1985. Elsevier Science, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

E, Stewart William, Schellekens Huub, International Society for Interferon Research., and Nederlandse Centrale Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek., eds. The biology of the interferon system 1985: Proceedings of the 1985 TNO-ISIR Meeting on the Interferon System held in Clearwater Beech, Florida, USA on 13-18 October, 1985. Elsevier Science, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Holger, Kirchner, Schellekens Huub, Nederlandse Centrale Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek., and International Society for Interferon Research., eds. The biology of the interferon system 1984: Proceedings of the 1984 TNO-ISIR Meeting on the Interferon System, held in Heidelberg, Federal Republic of Germany, on 21-25 October 1984. Elsevier Science, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ferdinando, Dianzani, Rossi G. B, International Society for Interferon Research., and International Ares-Serono Symposium on the Interferon System (1985 : Rome, Italy), eds. The Interferon system. Raven Press, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Anthony, Meager, ed. The Interferons: Characterization and application. Wiley-VCH, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1985), Laupheimer Interferon-Symposium (1st. Immuntherapie mit Interferonen: 1. Laupheimer Interferon-Symposium, Juni 1985. W. Zuckschwerdt, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jaqueline, De Maeyer-Guignard, ed. Interferons and other regulatory cytokines. Wiley, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

1957-, Jaffe Howard S., Bucalo Louis R. 1958-, and Sherwin Stephen A. 1948-, eds. Anti-infective applications of interferon-gamma. Dekker, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

G, Williams Bryan R., and Silverman Robert H. 1948-, eds. The 2-5A system: Molecular and clinical aspects of the interferon-regulated pathway : proceedings of the Sixth International Symposium of the Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada, June 3-5, 1985. A.R. Liss, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Interferoni"

1

Kotenko, Sergei V., and Raymond P. Donnelly. "Type III Interferons: The Interferon-λ Family." In The Interferons. Wiley-VCH Verlag GmbH & Co. KGaA, 2006. http://dx.doi.org/10.1002/3527608206.ch6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Samuel, Charles E., and Keiko Ozato. "Induction of interferons and interferon-induced genes." In Cytokine Yearbook Volume 1. Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-1616-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jacobsen, H. "Struktur und Wirkung von Interferonen." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Otto, U., S. Conrad, H. Baisch, and G. Klöppel. "Zur Evaluierung der Interferone im Nacktmausmodell: Möglichkeiten und Ergebnisse." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pralle, H. W. "Non Hodgkin-Lymphome und Interferon-Therapie eingeschlossen Haarzell-Leukämie, ausgeschlossen Multiples Myelom." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ludwig, H. "Interferon in der Behandlung des multiplen Myeloms." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Niederle, N. "Zur Behandlung myeloproliferativer Syndrome mit Interferonen." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

von Wussow, P. "Interferontherapie bei ausgewählten soliden Tumoren." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schmitz-Dräger, B. J., and R. Ackermann. "Die topische Behandlung solider Tumoren mit Interferonen." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lohmeyer, J. "AIDS und Interferone." In Interferone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-93383-7_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Interferoni"

1

Qiu, Zelin, Junfeng Li, and Yingyi Luo. "Spatial Attention in Interfering Speech Perception." In 2024 IEEE 14th International Symposium on Chinese Spoken Language Processing (ISCSLP). IEEE, 2024. https://doi.org/10.1109/iscslp63861.2024.10800449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chang, Jaewon, Jeong Ho Ryu, and Cheol Soo Lee. "Interfering Signal Transmission Using Multi-Frequency Beamforming." In 2024 IEEE Sensors Applications Symposium (SAS). IEEE, 2024. http://dx.doi.org/10.1109/sas60918.2024.10636385.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Borisov, Valery Alexandrovich, Boris Ivanovich Sanin, Svetlana Evgenievna Samsonova, Nikolaevna Harutyunyan Elena, and Borisovna Golubeva Dina. "THE EXPERIENCE OF DOMESTIC ANTIVIRAL AGENTS, AND SOME OF OWN APPROACHES IN THE TREATMENT OF CHRONIC HEPATITIS C IN ADULTS." In Themed collection of papers from Foreign intemational scientific conference «Joint innovation - joint development». Medical sciences . Part 2. Ьу НNRI «National development» in cooperation with PS of UA. June 2023. Crossref, 2023. http://dx.doi.org/10.37539/230629.2023.19.61.022.

Full text
Abstract:
In the management of 148 adult patients with chronic hepatitis C (CHC) of both sexes without special selection (taken into account only absolute contraindications to its performance) there were used domestic basic antiviral drugs - BAD| (short-living interferons (IFN) α, interferon inducers and nucleoside analogues) in parallel with additional antiviral drugs (drug glycyrrhizinic acid or amantadine) and maintenance therapy (stimulators of T-cell immunity and means of correction of side effects). Treatment was carried out in the framework of the developed complex of principles and approaches in
APA, Harvard, Vancouver, ISO, and other styles
4

Lau, Eric, Giuseppina Claps, David S. Hoon, and Ze'ev A. Ronai. "Abstract 4091: Interfering with interferon: An axis of ATF2-mediated chemoresistance." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jordan, Jarrat, Matteo Cesaroni, Jessica Schreiter, Chichi Huang, Marc Chevrier, and Jacqueline Benson. "II-21 Interfering with interferon in lupus: hitting the sweet spot with CNTO 6358." In Abstracts of the Third Biannual Scientific Meeting of the North and South American Lupus Community, Armonk, New York, USA, September 29 – October 1, 2016. Lupus Foundation of America, 2016. http://dx.doi.org/10.1136/lupus-2016-000179.51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Moneta, Gian Marco, Claudia Bracaglia, Ivan Caiello та ін. "AB0185 INTERFERON-Γ AMPLIFIES IMMUNE RESPONSE MEDIATED BY TYPE I INTERFERONS IN PAEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS AND CORRELATES WITH DISEASE ACTIVITY". У Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.7613.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Iravantchi, Yasha, Yang Zhang, Evi Bernitsas, Mayank Goel, and Chris Harrison. "Interferi." In CHI '19: CHI Conference on Human Factors in Computing Systems. ACM, 2019. http://dx.doi.org/10.1145/3290605.3300506.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"01 Targeting type I interferons." In 8th ANNUAL MEETING OF THE LUPUS ACADEMY, Warsaw, Poland, September 6–8, 2019. Lupus Foundation of America, 2019. http://dx.doi.org/10.1136/lupus-2019-la.13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tsai, Yu-Chen, Sidney Pestka, Lu-Hai Wang, Loren W. Runnels, and Leroy F. Liu. "Abstract 3438: Oncogenes-induced interferon-beta: modulation of tranformation phenotypes through interferon-ISG15 autocrine signaling." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dunga, Lucas Medeiros, Bruna Emanuelle Alves Pinto, Lucca Ferdinando Queiroz Fernandes, Matheus Araújo de Medeiros, and Bianca Etelvina Santos Oliveira. "Thyroid dysfunction with the continued use of beta interferon in the treatment of multiple sclerosis." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.691.

Full text
Abstract:
Introduction: The treatment of multiple sclerosis (MS) with beta interferon has been shown to be effective in reducing the number of relapses and the inflammatory activity of the disease, as well as slowing its progression. Although there are controversies in the literature, recent studies have pointed to the possibility of thyroid dysfunction as a side effect of prolonged use of beta interferon. Objectives: To analyze the presence of thyroid dysfunction due to the use of beta-interferon in patients with multiple sclerosis. Methods: That is a documentary, observational, and analytical study, w
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Interferoni"

1

Havell, Edward A. Actions of Interferons on Macrophages. Defense Technical Information Center, 1985. http://dx.doi.org/10.21236/ada157006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bello, Jake, and Judith O'Malley. Interferon Inducers against Infectious Diseases. Defense Technical Information Center, 1989. http://dx.doi.org/10.21236/adb134571.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bello, Jake, and Judith O'Malley. Interferon Inducers against Infectious Diseases. Defense Technical Information Center, 1990. http://dx.doi.org/10.21236/ada231360.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Levi, G. D. Jr, and K. E. Cheeks. Effects of interfering constituents on tritium smears. Office of Scientific and Technical Information (OSTI), 1993. http://dx.doi.org/10.2172/10161891.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Arlinghaus, Ralph B. Interfering Breast Cancer Metastases by Blocking NGAL Function. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada524471.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sastre, Adolfo G., and Connie S. Schmaljohn. Interferon Antagonism as a Common Virulence Factor of Hemorrhagic Fever Viruses. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada494593.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Johnson, Howard M. Interferon Agonists/Mimetics as Therapeutics for Smallpox and Other Respiratory Viruses. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada455389.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ivanova, Sonya, Raliza Skrobanska, Vera Kolyovska, Ivan Milanov, Valentina Dimitrova, and Veneta Bojinova. Neutralizing Antibodies against Interferon‑beta in Bulgarian Adolescent Multiple Sclerosis Patients. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2018. http://dx.doi.org/10.7546/crabs.2018.09.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kozina, Carol L., Matthew Wallace Moorman, Catherine Branda, et al. Investigation of type-I interferon dysregulation by arenaviruses : a multidisciplinary approach. Office of Scientific and Technical Information (OSTI), 2011. http://dx.doi.org/10.2172/1029825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sastre, Adolfo G., and Connie S. Schmaljohn. Interferon Antagonism as a Common Virulence Factor of Hemorrhagic Fever Viruses. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada479293.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Interferoni' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography